Genetic factors modifying response to glucocorticoid treatment in chronic pediatric inflammatory bowel diseases


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The article concerns genetic factors that determine efficiency of steroid treatment for chronic inflammatory bowel diseases (IBD) in children, focused, mostly, on Crohn disease and nonspecific ulcerative colitis. Their incidence comprises 5 to 15 per 100 000 children and adolescents. In acute phase, therapy of these diseases is based on salicylates and glucocorticoids which regulate cytokine network and immune cell functions. Application of high-dose glucocorticoids (GCs) exerts а sufficient immunosuppressive action. These effects are performed via specific GC receptors in the target cell populations. Hence, numbers and functionality of GC receptors are important for clinical response to GC treatment. The aim of this review is discern major genetic effects upon functioning of glucocorticoid receptors. Here we discuss effects of N363S, ER22/23EK, and NR3C1 variants, the most known GC functional gene polymorphisms. These gene variants are often associated with altered GC gene expression in individual cases of IBD. Moreover, some other gene variants are able to modulate the GC receptor expression, thus making it difficult to assess genetic predisposition to altered clinical response to glucocorticoids. Hence, the regulatory effects of single gene variants upon GC receptors may not show direct correlations with clinical effects of the drug. Therefore, we propose an immediate way to assess the gene activity, i. e., quantitative analysis of the gene transcription (mRNA detection) in the patients’ cells before and during glucocorticoid therapy, presuming further application of this parameter as a predictive marker for evaluation of optimal therapeutic response in the individual IBD patients.

全文:

受限制的访问

作者简介

Nadezhda Zaletova

St. Petersburg State Pediatric Medical University

Email: nadezhda-zaletova@yandex.ru
Postgraduate Student

Lubov Vostokova

St. Petersburg State Pediatric Medical University

Email: vostokova50@mail.ru
Research Associate, Laboratory of Molecular Diagnostics with a group for Ecogenetics, Research Center

Alexey Chukhlovin

St. Petersburg State Pediatric Medical University

Email: alexei.chukh@mail.ru
PhD, MD, Dr Med Sci, Head, Laboratory of Molecular Diagnostics with extended Group for Ecogenetics

Elena Kornienko

St. Petersburg State Pediatric Medical University

Email: elenkornienk@yandex.ru
PhD, MD, Professor, Head, Department of Gastroenterology

Anna Tretjak

St. Petersburg State Pediatric Medical University

Email: a.t.tretiak@gmail.com
Research Associate, Laboratory of Molecular Diagnostics with a group for Ecogenetics, Research Center

参考

  1. Загорский С. Э., Беляева Л. М. Хронические воспалительные заболевания кишечника у детей и подростков. Минск: БелМАПО; 2007.
  2. Ткачев А. В., Мкртчян Л. С., Никитина К. Е., Волынская Е. И. Воспалительные заболевания кишечника: на перекрестке проблем. Практическая медицина. 2012; 3; 17-22.
  3. Cao-Lei L., Leija S. C., Kumsta R. et al. Transcriptional control of the human glucocorticoid receptor: identification and analysis of alternative promoter regions. Hum. Genet. 2011; 129 (5): 533-43.
  4. Chen H. L., Li L. R. Glucocorticoid receptor gene polymorphisms and glucocorticoid resistance in inflammatory bowel disease: a meta-analysis. Dig. Dis. Sci. 2012; 57 (12): 3065-75.
  5. Cheong H. I., Kang H. G., Schlondorff J. GLCCI1 single nucleotide polymorphisms in pediatric nephrotic syndrome. Pediat. Nephrol. 2012; 27 (9): 1595-9.
  6. Cuzzoni E., De Iudicibus S., Bartoli F. et al. Association between BclI polymorphism in the NR3C1 gene and in vitro individual variations in lymphocyte responses to methylprednisolone. Br. J. Clin. Pharmacol. 2012; 73 (4): 651-5.
  7. De Iudicibus S., Franca R., Martelossi S. et al. Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. World J. Gastroenterol. 2011; 17 (9): 1095-1108.
  8. De Iudicibus S., Stocco G., Martelossi S. et al. Genetic predictors of glucocorticoid response in pediatric patients with inflammatory bowel diseases. J. Clin. Gastroenterol. 2011; 45 (1): e1-7.
  9. Fujii T., Hori H., Ota M., Hattori K. et al. Effect of the common functional FKBP5 variant (rs1360780) on the hypothalamic-pituitary-adrenal axis and peripheral blood gene expression. Psychoneuroendocrinology. 2014; 42: 89-97.
  10. Hold G. L., Smith M., Grange C. et al. Role of the gut microbiota in inflammatory bowel disease pathogenesis: What have we learnt in the past 10 years? World J. Gastroenterol. 2014; 20 (5): 1192-1210.
  11. Huizenga N. A., Koper J. W., De Lange P. et al. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J. Clin. Endocrinol. Metab. 1998; 83 (1): 144-51.
  12. Krupoves A., Mack D., Deslandres C. et al. Variation in the glucocorticoid receptor gene (NR3C1) may be associated with corticosteroid dependency and resistance in children with Crohn’s disease. Pharmacogenet. Genomics. 2011; 21 (8): 454-60.
  13. Liddicoat D. R., Kyparissoudis K., Berzins S. P. et al. The glucocorticoid receptor 1A3 promoter correlates with high sensitivity to glucocorticoid-induced apoptosis in human lymphocytes. Immunol. Cell Biol. 2014 Jul 22. doi: 10.1038/icb.2014.57.
  14. Maranville J. C., Luca F., Richards A. L. et al. Interactions between glucocorticoid treatment and cis-regulatory polymorphisms contribute to cellular response phenotypes. PLoS Genet. 2011 Jul;7 (7): e1002162. doi: 10.1371/journal.pgen.1002162.
  15. Maranville J. C., Baxter S. S., Witonsky D. B. et al. Genetic mapping with multiple levels of phenotypic information reveals determinants of lymphocyte glucocorticoid sensitivity. Am. J. Hum. Genet. 2013; 93 (4): 735-43.
  16. Niu N., Manickam V., Kalari K. R. et al. Human glucocorticoid receptor α gene (NR3C1) pharmacogenomics: gene resequencing and functional genomics. J. Clin. Endocrinol. Metab. 2009; 94 (8): 3072-84.
  17. Orii F., Ashida T., Nomura M. et al. Quantitative analysis for human glucocorticoid receptor alpha/beta mRNA in IBD. Biochem. Biophys. Res. Commun. 2002; 296 (5): 1286-94.
  18. Panek M., Pietras T., Szemraj J. et al. Association analysis of the glucocorticoid receptor gene (NR3C1) haplotypes (ER22/23EK, N363S, BclI) with mood and anxiety disorders in patients with asthma. Exp. Ther. Medicine. 2014; 8: 662-70.
  19. Quax R. A., van Laar J. A., van Heerebeek R. et al. Glucocorticoid sensitivity in Behçet’s disease. Endocr. Connect. 2012; 1 (2): 103-11.
  20. Russcher H., Smit P., van den Akker E. L. et al. Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression. J. Clin. Endocrinol. Metab. 2005; 90 (10): 5804-10.
  21. Towers R., Naftali T., Gabay G. et al. High levels of glucocorticoid receptors in patients with active Crohn’s disease may predict steroid resistance. Clin. Exp. Immunol. 2005; 141 (2): 357-62.
  22. Tsartsali L., Papadopoulos M., Lagona E. et al. Association of hypothalamic-pituitary-adrenal axis-related polymorphisms with stress in asthmatic children on inhaled corticosteroids. Neuroimmunomodulation. 2012;19 (2): 88-95.
  23. Xiang L., Marshall GD Jr. Glucocorticoid receptor BclI polymorphism associates with immunomodulatory response to stress hormone in human peripheral blood mononuclear cells. Int. J. Immunogenet. 2013; 40 (3): 222-9.
  24. Zou Y. F., Xu J. H., Wang F. et al. Association study of glucocorticoid receptor genetic polymorphisms with efficacy of glucocorticoids in systemic lupus erythematosus: a prospective cohort study. Autoimmunity. 2013; 46 (8): 531-36.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Zaletova N.K., Vostokova L.P., Chukhlovin A.B., Kornienko E.A., Tretjak A.T., 2015

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 69634 от 15.03.2021 г.